Skip to main content

Disorders of Potassium Metabolism

  • Chapter
  • 309 Accesses

Abstract

The concentration of potassium in our cells is some 37 times higher than in the extracellular compartment. Maintenance of this transcellular concentration gradient is central for normal cell function in general and for nerve conduction and muscle contraction in particular. Not surprisingly, multiple homeostatic mechanisms regulate the internal distribution of K+, as well as maintaining body K+ stores stable. Disorders of K+ metabolism occur when one or more of these systems is disrupted. Such disorders are often asymptomatic or only associated with mild and nonspecific symptoms. As a result, they are usually first detected, sometimes incidentally, by uncovering an abnormality in serum potassium concentration ([K+]). Although often asymptomatic, disorders of K+ metabolism can also produce life-threatening cardiac arrhythmias or paralyses with little or no warning. In such instances, the ability to recognize the problem and intervene in a timely fashion can be lifesaving. Management of disorders of K+ metabolism is based firmly on an understanding of normal K+ homeostasis. As a necessary introduction to these disorders, a brief review of normal K+ balance is presented below.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Holbrook JT, Patterson KY, Bodner JE, Douglas LW, Veillon C, Kelsay JL, Mertz W, Smith JC: Sodium and potassium intake and balance in adults consuming self-selected diets. Am J Clin Nutr 40: 786–793, 1984.

    PubMed  CAS  Google Scholar 

  2. Hiatt N, Davidson MB, Bonorris G: The effect of potassium chloride infusion on insulin secretion in vivo. Horm Metab Res 4: 64–68, 1972.

    Article  PubMed  CAS  Google Scholar 

  3. Dluhy RG, Axelrod L, Williams GH: Serum immunoreactive insulin and growth hormone response to potassium infusion in normal man. J Appl Physiol 33: 22–26, 1972.

    PubMed  CAS  Google Scholar 

  4. Santeusanio F, Faloona GR, Knochel JP, Unger RH: Evidence for a role of endogenous insulin and glucagon in the regulation of potassium homeostasis. J Lab Clin Med 81: 809817, 1973.

    Google Scholar 

  5. Martinez R, Rietberg B, Skyler J, Oster JR, Perez GO: Effect of hyperkalemia on insulin secretion. Experientia 47: 270272, 1991.

    Google Scholar 

  6. Clausen T, Everts ME: Regulation of the Na, K-pump in skeletal muscle. Kidney Int 35: 1–13, 1989.

    Article  PubMed  CAS  Google Scholar 

  7. Zierler K, Rogus EM: Rapid hyperpolarization of rat skeletal muscle induced by insulin. Biochim Biophys Acta 640: 687692, 1981.

    Google Scholar 

  8. Clausen T, Flatman JA: Effects of insulin and epinephrine on Na’-K’ and glucose transport in soleus muscle. Am J Physiol 252: E492 - E499, 1987.

    PubMed  CAS  Google Scholar 

  9. Minaker KL, Rowe JW: Potassium homeostasis during hyperinsulinemia: Effect of insulin level, [3-blockade, and age. Am J Physiol 242: E373 - E377, 1982.

    PubMed  CAS  Google Scholar 

  10. Zierler KL: Effect of insulin on potassium efflux from rat muscle in the presence and absence of glucose. Am J Physiol 198: 1066–1070, 1960.

    PubMed  CAS  Google Scholar 

  11. DeFronzo RA, Sherwin RS, Dillingham M, Hendler R, Tamborlane WV, Felig P: Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. J Clin Invest 61: 472–479, 1978.

    Article  PubMed  CAS  Google Scholar 

  12. Rowe JW, Tobin JD, Rosa RM, Andres R: Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 29: 498–502, 1980.

    Article  PubMed  CAS  Google Scholar 

  13. Landsberg L, Young JB: Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med 298: 1295 1301, 1978.

    Google Scholar 

  14. Rosa RM, Silva P, Young JB, Landsberg L, Brown RS, Rowe JW, Epstein FH: Adrenergic modulation of extrarenal potassium homeostasis. N Engl J Med 302: 431–434, 1980.

    Article  PubMed  CAS  Google Scholar 

  15. DeFronzo RA, Bia M, Birkhead G: Epinephrine and potassium disposal. Kidney Int 20: 83–91, 1981.

    Article  PubMed  CAS  Google Scholar 

  16. Brown MJ, Brown DC, Murphy MB: Hypokalemia from betaz receptor stimulation by circulating epinephrine. N Engl J Med 309: 1414–1419, 1983.

    Article  PubMed  CAS  Google Scholar 

  17. Pedersen EB, Kornerup HJ: Relationship between plasma aldosterone concentration and plasma potassium in patients with essential hypertension during alprenolol treatment. Acta Med Scand 200: 263–267, 1976.

    Article  PubMed  CAS  Google Scholar 

  18. Drayer JIM, Weber MA, Longworth DL, Laragh JH: The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol. Am J Med 64: 187–192, 1978.

    Article  PubMed  CAS  Google Scholar 

  19. McKenna TJ, Island DP, Nicholson WE, Liddle GW: The effects of potassium on early and late steps in aldosterone biosynthesis in cells of the zona glomerulosa. Endocrinology 103: 1411–1416, 1978.

    Article  PubMed  CAS  Google Scholar 

  20. Gann DS, Delea CS, Gill JR Jr, Thomas JP, Bartter FC: Control of aldosterone secretion by change of body potassium in normal man. Am J Physiol 207: 104–108, 1964.

    PubMed  CAS  Google Scholar 

  21. Kassirer JP, Appleton FM, Chazan JA, Schwartz WB: Aldosterone in metabolic alkalosis. J Clin Invest 46: 1558–1571, 1967.

    Article  PubMed  CAS  Google Scholar 

  22. Pratt JH: Role of angiotensin II in potassium-mediated stimulation of aldosterone secretion in the dog. J Clin Invest 70: 667–672, 1982.

    Article  PubMed  CAS  Google Scholar 

  23. Stanton BA: Regulation of Na’ and K’ transport by mineralocorticoids. Semin Nephrol 7: 82–90, 1987.

    PubMed  CAS  Google Scholar 

  24. Wang W, Schwab A, Giebisch G: Regulation of small conductance K. channel in apical membrane of rat cortical collecting tubule. Am J Physiol 250: F494 - F502, 1990.

    Google Scholar 

  25. Himathongkam T, Dluhy RG, Williams GH: Potassiumaldosterone-renin interrelationships. J Clin Endocrinol Metab 41: 153–159, 1975.

    Article  PubMed  CAS  Google Scholar 

  26. Keith NM, Osterberg AE, Burchell HB: Some effects of potassium salts in man. Ann Intern Med 16: 879–892, 1942.

    Article  CAS  Google Scholar 

  27. Clive DM, Gurwitz JH, Rossetti RG: Potassium homeostasis with indomethacin therapy in normal subjects. Am J Kidney Dis 19: 16–21, 1992.

    PubMed  CAS  Google Scholar 

  28. DeFronzo RA, Taufield PA, Black H, McPhedran P, Cooke CR: Impaired renal tubular potassium secretion in sickle cell diseasè. Ann Intern Med 90: 310–316, 1979.

    Article  PubMed  CAS  Google Scholar 

  29. Brown RS: Extrarenal potassium homeostasis. Kidney Int 30: 116–127, 1986.

    Article  PubMed  CAS  Google Scholar 

  30. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM: Cloning of human mineralocorticoid receptor complementary DNA: structural and func- tional kinship with the glucocorticoid receptor. Science 237: 268–275, 1987.

    Article  PubMed  CAS  Google Scholar 

  31. Armanini D, Strasser T, Weber PC: Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am J Physiol 248: E388 - E390, 1985.

    PubMed  CAS  Google Scholar 

  32. Meyer WJ, Nichols NR: Mineralocorticoid binding in cultured smooth muscle cells and fibroblasts from rat aorta. J Steroid Biochem 14: 1157–1168, 1981.

    Article  PubMed  CAS  Google Scholar 

  33. Ikeda U, Hyman R, Smith TW, Medford RM: Aldosteronemediated regulation of Na’, K’-ATPase gene expression in adult and neonatal rat cardiocytes. J Biol Chem 266: 120581 2066, 1991.

    Google Scholar 

  34. Clark BA, Brown RS, Epstein FH: Effect of atrial natriuretic peptide on potassium-stimulated aldosterone secretion: potential relevance to hypoaldosteronism in man. J Clin Endocrinol Metab 75: 399–403, 1992.

    Article  PubMed  CAS  Google Scholar 

  35. Nicolis GL, Kahn T, Sanchez A, Gabrilove L: Glucose-induced hyperkalemia in diabetic subjects. Arch Intern Med 141: 49–53, 1981.

    Article  PubMed  CAS  Google Scholar 

  36. Williams ME, Rosa RM, Silva P, Brown RS, Epstein FH: Impairment of extrarenal potassium disposal by a-adrenergic stimulation. N Engl J Med 311: 145–149, 1984.

    Article  PubMed  CAS  Google Scholar 

  37. Todd EP, Vick RL: Kalemotropic effect of epinephrine: analysis with adrenergic agents and antagonists. Am J Physiol 220: 1964–1969, 1971.

    PubMed  CAS  Google Scholar 

  38. Williams ME, Gervino EV, Rosa RM, Landsberg L, Young JB, Silva P, Epstein FH: Catecholamine modulation of rapid potassium shifts during exercise. N Engl J Med 312: 823–827, 1985.

    Article  PubMed  CAS  Google Scholar 

  39. Kjeldsen K, NOrgaard A, Gatzsche CO, Thomassen A, Clausen T: Effect of thyroid function on number of Na-K pumps in human skeletal muscle. Lancet 2: 8–10, 1984.

    Article  PubMed  CAS  Google Scholar 

  40. Sugarman A, Kahn T: Parathyroid hormone impairs extrarenal potassium tolerance in the rat. Am J Physiol 254: F385 - F390, 1988.

    PubMed  CAS  Google Scholar 

  41. Sugarman A, Kahn T: Calcium channel blockers enhance extrarenal potassium disposal in the rat. Am J Physiol 250: F695 - F701, 1986.

    PubMed  CAS  Google Scholar 

  42. D¢rup I, Skajaa K, Clausen T, Kjeldsen K: Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during diuretic treatment. Br Med J 296: 455–458, 1988.

    Article  Google Scholar 

  43. Kjeldsen K, Nargaard A, Clausen T: Effect of K-depletion on 3H-ouabain binding and Na-K-contents in mammalian skeletal muscle. Acta Physiol Scand 122: 103–117, 1984.

    Article  PubMed  CAS  Google Scholar 

  44. Adrogué HG, Madias NE: Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med 71: 456–467, 1981.

    Article  PubMed  Google Scholar 

  45. Burnell JM, Villamil MF, Uyeno BT, Scribner BH: The effect in humans of extracellular pH change on the relationship between serum potassium concentration and intracellular potassium. J Clin Invest 35: 935–939, 1956.

    Article  PubMed  CAS  Google Scholar 

  46. Oster JR, Perez GO, Castro A, Vaamonde CA: Plasma potassium response to acute metabolic acidosis induced by mineral and nonmineral acids. Mineral Electrolyte Metab 4: 28–36, 1980.

    CAS  Google Scholar 

  47. Orringer CE, Eustace JC, Wunsch CD, Gardner LB: Natural history of lactic acidosis after grand-mal seizures: a model for the study of an anion-gap acidosis not associated with hyperkalemia. N Engl J Med 297: 796–799, 1977.

    Article  PubMed  CAS  Google Scholar 

  48. Fulop M: Serum potassium in lactic acidosis and ketoacidosis. N Engl J Med 300: 1087–1089, 1979.

    Article  PubMed  CAS  Google Scholar 

  49. Adrogué HG, Chap Z, Ishida T, Field JB: Role of the endocrine pancreas in the kalemic response to acute metabolic acidosis in conscious dogs. J Clin Invest 75: 798–808, 1985.

    Article  PubMed  Google Scholar 

  50. Gennari FJ, Cohen Ji: Role of the kidney in potassium homeostasis: lessons from acid-base disturbances. Kidney Int 8: 1–5, 1975.

    Article  PubMed  CAS  Google Scholar 

  51. Krapf R, Cadoff P, Wagdi P, Stäubli M, Hulter HN: The plasma potassium response to acute respiratory alkalosis. Kidney Int 47: 217–224, 1995.

    Article  PubMed  CAS  Google Scholar 

  52. Wright FS, Giebisch G: Renal potassium transport: Contributions of individual nephron segments and populations. Am J Physiol 235: F515 - F527, 1978.

    PubMed  CAS  Google Scholar 

  53. Wright FS, Giebisch G: Regulation of potassium excretion. In: DW Seldin, G Giebisch, eds, The Kidney, 2nd ed. Raven Press, New York, pp 2209–2247, 1992.

    Google Scholar 

  54. Field MJ, Giebisch G: Hormonal control of renal potassium excretion. Kidney Int 27: 379–387, 1985.

    Article  PubMed  CAS  Google Scholar 

  55. Seldin DW, Welt LG, Cort JH: The role of sodium salts and adrenal steroids in the production of hypokalemic alkalosis. Yale J Biol Med 29: 229–247, 1956.

    PubMed  CAS  Google Scholar 

  56. Good DW, Wright FS: Luminal influences on potassium secretion: Sodium concentration and fluid flow rate. Am J Physiol 236: F192 - F205, 1979.

    PubMed  CAS  Google Scholar 

  57. Stokes JB: Potassium secretion by cortical collecting tubule: relation to sodium absorption, luminal sodium concentration, and transepithelial voltage. Am J Physiol 241: F395 - F402, 1981.

    PubMed  CAS  Google Scholar 

  58. Relman AS, Schwartz WB: The effect of DOCA on electrolyte balance in normal man and its relation to sodium chloride intake. Yale J Biol Med 24: 540–558, 1952.

    PubMed  CAS  Google Scholar 

  59. Schwartz WB, Jenson RL, Reiman AS: Acidification of the urine and increased ammonium excretion without change in acid-base equilibrium: sodium reabsorption as a stimulus to the acidifying process. J Clin Invest 34: 673–680, 1955.

    Article  PubMed  CAS  Google Scholar 

  60. Velazquez H, Wright FS, Good DW: Luminal influences on potassium secretion: chloride replacement with sulfate. Am J Physiol 242: F46 - F55, 1982.

    PubMed  CAS  Google Scholar 

  61. Velazquez H, Ellison DH, Wright FS: Chloride-dependent potassium secretion in early and late renal distal tubules. Am J Physiol 253: F555 - F562, 1987.

    PubMed  CAS  Google Scholar 

  62. Stanton BA, Giebisch G: Effects of pH on potassium transport by renal distal tubule. Am J Physiol242:F544–F551,1982.

    Google Scholar 

  63. Stanton BA, Giebisch GH: Potassium transport by the renal distal tubule: effects of potassium loading. Am J Physiol 243: F487 - F493, 1982.

    PubMed  CAS  Google Scholar 

  64. Hayslett JP, Binder HJ: Mechanism of potassium adaptation. Am J Physiol 243: F103 - F112, 1982.

    PubMed  CAS  Google Scholar 

  65. Doucet A, Marsy S: Characterization of K-ATPase activity in distal nephron: stimulation by potassium depletion. Am J Physiol 253: F418 - F423, 1987.

    PubMed  CAS  Google Scholar 

  66. Wingo CS: Potassium transport by medullary collecting tubule of rabbit: effects of variation in K’ intake. Am J Physiol 253: F1136 - F1141, 1987.

    PubMed  CAS  Google Scholar 

  67. Wingo CS: Active proton secretion and potassium absorption in the rabbit outer medullary collecting duct. Functional evidence for proton-potassium-activated adenosine triphosphatase. J Clin Invest 84: 361–365, 1989.

    Article  PubMed  CAS  Google Scholar 

  68. Hayes CP Jr, McLeod ME, Robinson RR: An extrarenal mechanism for the maintenance of potassium balance in severe chronic renal failure. Trans Assoc Am Physicians 80: 207–216, 1967.

    PubMed  Google Scholar 

  69. Paice BJ, Paterson KR, Onyanga-Omara F, Donnelly T, Gray JMB, Lawson DH: Record linkage study of hypokalaemia in hospitalized patients. Postgrad Med J 62: 187–191, 1986.

    Article  PubMed  CAS  Google Scholar 

  70. Lawson DH, Henry DA, Lowe JM, Gray JMB, Morgan HG: Severe hypokalemia in hospitalized patients. Arch Intern Med 139: 978–980, 1979.

    Article  PubMed  CAS  Google Scholar 

  71. Adams PC, Woodhouse KW, Adela M, Parnham A: Exaggerated hypokalaemia in acute myeloid leukemia. Br Med 282: 1034–1035, 1981.

    Article  CAS  Google Scholar 

  72. Naparstek Y, Gutman A: Spurious hypokalemia in myeloproliferative disorders. Am J Med Sci 288: 175–177, 1984.

    Article  PubMed  CAS  Google Scholar 

  73. Depner TA, Magee JA: Severe hypokalemia associated with pseudohypoxemia in acute nonlymphocytic leukemia. West J Med 149: 332–334, 1988.

    PubMed  CAS  Google Scholar 

  74. Khuri RN, Agulian SK, Abdulnour-Nakhoul S, Nakhoul NL: Electrochemical potentials of potassium in skeletal muscle under different metabolic states. J Cell Physiol 153: 534–538, 1992.

    Article  PubMed  CAS  Google Scholar 

  75. Surawicz B: Relationship between electrocardiogram and electrolytes. Am Heart J 73: 814–834, 1967.

    Article  PubMed  CAS  Google Scholar 

  76. Fisch C: Relation of electrolyte disturbances to cardiac arrhythmias. Circulation 47: 408–419, 1973.

    Article  PubMed  CAS  Google Scholar 

  77. Nordrehaug JE: Malignant arrhythmias in relation to serum potassium values in patients with an acute myocardial infarction. Acta Med Scan (Suppl) 647: 101–107, 1981.

    CAS  Google Scholar 

  78. Hulting J: In-hospital ventricular fibrillation and its relation to serum potassium. Acta Med Scand (Suppl) 647: 109–116, 1981.

    CAS  Google Scholar 

  79. Schulman M, Narins RG: Hypokalemia and cardiovascular disease. Am J Cardiol 65: 4E - 9E, 1990.

    Article  PubMed  CAS  Google Scholar 

  80. Duke M: Thiazide-induced hypokalemia. Association with acute myocardial infaction and ventricular fibrillation. JAMA 239: 43–45, 1978.

    CAS  Google Scholar 

  81. Brunner HR, Baer L, Sealey JE, Ledingham JGG, Laragh JH: The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest 49: 2128–2138, 1970.

    Article  PubMed  CAS  Google Scholar 

  82. Carliner NH, Schelling J-L, Russell RP, Okun R, Davis M: Thiazide-and phthalimidine-induced hyperglycemia in hypertensive patients. JAMA 191: 535–540, 1965.

    CAS  Google Scholar 

  83. Conn JW: Hypertension, the potassium ion and impaired carbohydrate tolerance. N Engl J Med 273: 1135–1143, 1965.

    Article  PubMed  CAS  Google Scholar 

  84. Schwartz WB, Relman AS: Effects of electrolyte disorders on renal structure and function. N Engl J Med 276: 383–389, 1967.

    Article  PubMed  CAS  Google Scholar 

  85. Manitius A, Levitin H, Beck D, Epstein FH: On the mechanism of impairment of renal concentrating ability in potassium deficiency. J Clin Invest 39: 684–692, 1960.

    Article  PubMed  CAS  Google Scholar 

  86. Krishna GG, Miller E, Kapoor S: Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 320: 1177–1182, 1989.

    Article  PubMed  CAS  Google Scholar 

  87. Krishna GG: Effect of potassium intake on blood pressure. J Am Soc Nephrol 1: 43–52, 1990.

    PubMed  CAS  Google Scholar 

  88. Knochel JP: Neuromuscular manifestations of electrolyte disorders. Am J Med 72: 521–535, 1982.

    Article  PubMed  CAS  Google Scholar 

  89. Campion DS, Arias M, Carter NW: Rhabdomyolysis and myoglobinuria. Association with hypokalemia of renal tubular acidosis. JAMA 220: 967–969, 1972.

    CAS  Google Scholar 

  90. Christiensen KS: Hypokalemic periodic paralysis secondary to renal tubular acidosis. Eur Neurol 24: 303–305, 1985.

    Article  Google Scholar 

  91. Alvarez J, Low RB: Acute respiratory arrest due to hypokalemia. Ann Emerg Med 17: 288–289, 1988.

    Article  PubMed  CAS  Google Scholar 

  92. Morgan DB, Young RM: Acute transient hypokalaemia: new interpretation of a common event. Lancet 2: 751–752, 1982.

    Article  PubMed  CAS  Google Scholar 

  93. Wadstein J, Skude G: Does hypokalaemia precede delirium tremens? Lancet 2: 549–550, 1978.

    Article  PubMed  CAS  Google Scholar 

  94. Laso FJ, Gonzalez-Buitrago JM, Martin-Ruiz C, Vicens E, Moyano JC: Inter-relationship between serum potassium and plasma catecholamines and 3’:5’ cyclic monophosphate in alcohol withdrawal. Drug Alcohol Depend 26: 183–188, 1990.

    Article  PubMed  CAS  Google Scholar 

  95. Bremner P, Burgess C, Beasley R, Woodman K, Marshall S, Crane J, Pearce N: Nebulized fenoteral causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med 86: 419–423, 1992.

    Article  PubMed  CAS  Google Scholar 

  96. Burgess CD, Flatt A, Siebers R, Crane J, Beasley R, Purdie G: A comparison of the extent and duration of hypokalaemia following three nebulized Betaz adrenoceptor agonists. EurJ Clin Pharmacol 36: 415–417, 1989.

    Article  CAS  Google Scholar 

  97. McCleave DJ, Phillips PJ, Vedig AE: Compartmental shift of potassium—a result of sympathomimetic overdose. Aust NZ J Med 8: 180–183, 1978.

    Article  CAS  Google Scholar 

  98. Kearney TE, Manoguerra AS, Curtis GP, Ziegler MG: Theophylline toxicity and the beta-adrenergic system. Ann Intern Med 102: 766–769, 1985.

    Article  PubMed  CAS  Google Scholar 

  99. Atuk NO, Blaydes MC, Westervelt FB Jr, Wood JE Jr: Effect of aminophylline on urinary excretion of epinephrine and norepinephrine in man. Circulation 35: 745 753, 1967.

    Google Scholar 

  100. Zantvoort FA, Derkx FHM, Boomsma F, Roos PJ, Schalekamp MADH: Theophylline and serum electrolytes. Ann Intern Med 104: 134, 1986.

    Article  PubMed  CAS  Google Scholar 

  101. Shannon M, Lovejoy FH Jr: Hypokalemia after theophylline intoxication: the effects of acute vs chronic poisoning. Arch Intern Med 149: 2725–2729, 1989.

    Article  PubMed  CAS  Google Scholar 

  102. Passmore AP, Kondowe GB, Johnston GD: Caffeine and hypokalemia. Ann Intern Med 105: 468, 1986.

    Article  PubMed  CAS  Google Scholar 

  103. Minella RA, Schulman DS: Fatal verapamil toxicity and hypokalemia. Am Heart J 121: 1810–1812, 1991.

    Article  PubMed  CAS  Google Scholar 

  104. Lofaso F, Baud FJ, Halna du Fretay X, Bismuth C, Staikowsky F, Sidhom N: Hypokaliémie an cours d’intoxications massives par la chloroquine. Presse Med 16: 22–24, 1987.

    PubMed  CAS  Google Scholar 

  105. Liu GZ, Lyle KC, Cao J: Experiences with gossypol as a male pill. Am J Obstet Gynecol 157: 1079–1081, 1987.

    PubMed  CAS  Google Scholar 

  106. Tam S-C: Acute hypokalemic effect of gossypol. Can J Physiol Pharmacol 64: 881–884, 1986.

    Article  PubMed  CAS  Google Scholar 

  107. Ober KP: Thyrotoxic periodic paralysis in the United States. Medicine 71: 109–120, 1992.

    Article  PubMed  CAS  Google Scholar 

  108. Chronos N, Mendel P, Ozin RL: Thyrotoxicosis presenting as life threatening hypokalaemic paralysis: investigation of the Na/K pump in isolated leukocytes. Br J Clin Pract 47: 106108, 1993.

    Google Scholar 

  109. Oh VMS, Taylor EA, Yeo S-H, Lee K-O: Cation transport across lymphocyte plasma membranes in euthyroid and thyrotoxic men with and without hypokalaemic periodic paralysis. Clin Sci 78: 199–206, 1990.

    PubMed  CAS  Google Scholar 

  110. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R: In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. Br Med J 303: 1096–1099, 1991.

    Article  CAS  Google Scholar 

  111. Kjeldsen K, Nt rgaard A, G¢tzsche CO, Thomassen A, Clausen T: Effect of thyroid function on number of Na–K pumps in human skeletal muscle. Lancet 2: 8–10, 1984.

    Article  PubMed  CAS  Google Scholar 

  112. Conway MJ, Seibel JA, Eaton RP: Thyrotoxicosis and peri- 133. odic paralysis: improvement with beta blockade. Ann Intern Med 81: 332–336, 1974. 134.

    Google Scholar 

  113. Yeung RTT, Tse TF: Thyrotoxic periodic paralysis. Am J Med 57: 584–590, 1974.

    Article  PubMed  CAS  Google Scholar 

  114. Johnsen T: Familial periodic paralysis with hypokalaemia. Dan Med Bull 28: 1–27, 1981. 135.

    Google Scholar 

  115. Kantola IM, Tarssanen LT: Familial hypokalaemic periodic paralysis in Finland. J Neurol Neurosurg Psychiatr 55: 322324, 1992. 136.

    Google Scholar 

  116. Corbett VA, Nuttall FQ: Familial hypokalemic periodic paralysis in blacks. Ann Intern Med 83: 63–65, 1975.

    Article  PubMed  CAS  Google Scholar 

  117. Minaker KL, Meneilly GS, Flier JS, Rowe JW: Insulin- 137. mediated hypokalemia and paralysis in familial hypokalemic periodic paralysis. Am J Med 84: 1001–1006, 1988.

    Article  PubMed  CAS  Google Scholar 

  118. Stedwell RE, Allen KM, Binder LS. Hypokalemic paralyses: a review of the etiologies, pathophysiology, presentation, and 138. therapy. Am J Emerg Med 10: 143–148, 1992.

    Article  PubMed  CAS  Google Scholar 

  119. Baruma OJS, Bots GTAM, Went LN: Familial hypokalemic periodic paralysis. 50 year followup of a large family. Arch 139. Neurol 42: 28–31, 1985.

    Google Scholar 

  120. Links TP, Zwartz MJ, Wilmink JT, Molenaar WM, 140. Oosterhius HJGH: Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and 141. pathological aspects. Brain 113: 1873–1889, 1990.

    Article  PubMed  Google Scholar 

  121. Streeten DHP, Speller PJ, Fellerman H: Use of corticotropin-induced potassium changes in the diagnosis of both hypo-and hyperkalemic periodic paralysis. Eur Neurol 142. 33: 103–108, 1993.

    Article  Google Scholar 

  122. Vroom FQ, Jarrell MA, Maren TH: Acetozolamide treatment of hypokalemic periodic paralysis. Arch Neurol 32:385— 143. 392, 1975.

    Google Scholar 

  123. Jarrell MA, Greer M, Maren TH: The effect of acidosis in 144. hypokalemic periodic paralysis. Arch Neurol 33: 791–793, 1976. 145.

    Google Scholar 

  124. Johnson CH, Van Tassell VJ: Acute barium poisoning with respiratory failure and rhabdomyolysis. Ann Emerg Med 20: 1138–1142, 1991. 146.

    Google Scholar 

  125. Shankle R, Keane JR: Acute paralysis from inhaled barium carbonate. Arch Neurol 45: 579–580, 1988. 147.

    Google Scholar 

  126. Hesp R, Chanarin I, Tait CE: Potassium changes in megaloblastic anaemia. Clin Sci Mol Med 49: 77–79, 1975.

    PubMed  CAS  Google Scholar 

  127. Rao TLK, Mathru M, Salem MR, Adel AE: Serum potassium levels following transfusions of frozen erythrocytes. An- 148. esthesiology 52: 170–172, 1980.

    CAS  Google Scholar 

  128. Weinsier RL, Bacon J, Butterworth CE Jr: Central venous alimentation: a prospective study of the frequency of meta- 149. bolic abnormalities among medical and surgical patients. Journal of Parenteral and Enteral Nutrition 6: 421–425, 1982.

    Article  PubMed  CAS  Google Scholar 

  129. Hernandez RE, Schambelan M, Cogan MG, Colman J, 150. Morris RC Jr, Sebastian A: Dietary NaC1 determines the severity of potassium depletion-induced metabolic alkalosis. 151. Kidney Int 31: 1356–1367, 1987.

    Article  PubMed  CAS  Google Scholar 

  130. Squires RD, Huth EJ: Experimental potassium depletion in normal human subjects. I. Relation of ionic intakes to the 152. renal conservation of potassium. J Clin Invest 38: 1134–1148, 1959. 153.

    Google Scholar 

  131. Silva P, Spokes K: Sympathetic system in potassium homeostasis. Am J Physiol 241: F151 — F155, 1981.

    PubMed  CAS  Google Scholar 

  132. Drenick EJ, Bland W, Singer FR, Lederer M: Body 154. potassium content in obese subjects and potassium depletion during prolonged fasting. Am J Clin Nutr 18: 278–285, 155. 1966.

    Google Scholar 

  133. Garrow JS: Total body-potassium in kwashiorkor and marasmus. Lancet 2: 455–458, 1965.

    Article  PubMed  CAS  Google Scholar 

  134. Bonne OB, Bloch M, Berry EM: Adaptation to severe chronic hypokalemia in anorexia nervosa: a plea for conservative mananagement. Int J Eating Disorders 13: 125–128, 1993.

    Article  CAS  Google Scholar 

  135. Harris RT: Bulimarexia and related serious eating disorders with medical complications. Ann Intern Med 99: 800–807, 1983.

    Article  PubMed  CAS  Google Scholar 

  136. Knochel JP, Dotin LN, Hamburger RJ: Pathophysiology of intense physical conditioning in a hot climate. J Clin Invest 51: 242–255, 1972.

    Article  PubMed  CAS  Google Scholar 

  137. Hart GR, Anderson RI, Crumpler CP, Shulkin A, Reed G, Knochel JP: Epidemic classical heat stroke: clinical characteristics and course of 28 patients. Medicine 61: 189–197, 1982.

    Article  PubMed  CAS  Google Scholar 

  138. Foster ES, Hayslett JP, Binder HJ: Mechanism of active potassium absorption and secretion in the rat colon. Am J Physiol 246: G611 — G617, 1984.

    PubMed  CAS  Google Scholar 

  139. Fordtran JS: Speculations on the pathogenesis of diarrhea. Fed Proc 26: 1405–1414, 1967.

    PubMed  CAS  Google Scholar 

  140. Reid AC, Draper IT: Flaccid quadriparesis due to salmonella enteritis. Scot Med J 25: 129–130, 1980.

    PubMed  CAS  Google Scholar 

  141. daSilva OA, Amaral CFS, daSilveira JCB, López M, Pittella JEH: Hyperkalemic respiratory muscle paralysis following strongyloides stercoralis hyperinfection. Am J Trop Med Hyg 30: 69–73, 1981.

    CAS  Google Scholar 

  142. Orman RA, Lewis JB Jr: Flaccid quadriparesis associated with yersinia enterocolitis-induced hypokalemia. Arch Intern Med 149: 1193–1194, 1989.

    Article  PubMed  CAS  Google Scholar 

  143. Lopez AP, Gorbach LS: Diarrhea in AIDS. Infect Dis Clin North Am 2: 705–718, 1988.

    PubMed  CAS  Google Scholar 

  144. Guerra I, Kimmel PL: Hypokalemic adrenal crisis in a patient with AIDS. South Med J 84: 1265–1267, 1991.

    Article  PubMed  CAS  Google Scholar 

  145. Schwartz WB, Reiman AS: Metabolic and renal studies in chronic potassium depletion resulting from overuse of laxatives. J Clin Invest 32: 258–271, 1953.

    Article  PubMed  CAS  Google Scholar 

  146. Basser LS: Purgatives and periodic paralysis. Med J Aust 1: 47–48, 1979.

    PubMed  CAS  Google Scholar 

  147. Meyers AM, Feldman C, Sonnekus MI, Ninin DT, Margolius LP, Whalley NA: Chronic laxative abusers with pseudo-idiopathic oedema and autonomous pseudo-Bartter’s syndrome. S Afr Med J 78: 631–636, 1990.

    PubMed  CAS  Google Scholar 

  148. Simodynes E: Preoperative shock secondary to severe hypokalemia and hypocalcemia from recreational enemas. Anesth Analg 60: 762 763, 1981.

    Google Scholar 

  149. O’Dorisio TM, Mekhjian HS, Gaginella TS: Medical therapy of VlPomas. Endocrinol Metab Clin North Am 18: 545–556, 1989.

    PubMed  Google Scholar 

  150. Schrock LG, Polk HC Jr: Rectal villous adenoma producing hypokalemia. Am Surgeon 40: 54–59, 1974.

    PubMed  CAS  Google Scholar 

  151. Chisholm JC Jr: Zollinger—Ellison syndrome: intermittent diarrhea, relentless hypokalemia, and hypergastrinemia. J Nati Med Assoc 73: 1151–1154, 1981.

    Google Scholar 

  152. Verner JV, Morrison AB: Endocrine pancreatic islet disease with diarrhea. Arch Intern Med 133:492–500, 1974. Campbell JM, Hunt TK, Karam JH, Forsham PH: Jejunoileal bypass as a treatment of morbid obesity. Arch Intern Med 137: 602–610, 1977.

    Article  Google Scholar 

  153. Cooke WT: Water and electrolyte upsets in the stratorrhea syndrome. J Mt Sinai Hosp 24:221–231, 1957. Holmberg C, Perheentupa J, Launiala K, Hallman N: Con- genital chloride diarrhoea. Arch Dis Child 52: 255–267, 1977.

    Article  Google Scholar 

  154. Slavin RE, Dias MA, Saral R: Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients. Cancer 42: 1747–1759, 1978.

    Article  PubMed  CAS  Google Scholar 

  155. Murai K, Tsuruta K, Yamamura Y, Kuribayashi T, Kurihara T, Matsukura S: Hypokalemic myopathy associated with radiation enteropathy. Eur Neurol 25: 444–447, 1986.

    Article  PubMed  CAS  Google Scholar 

  156. Gonzalez JJ, Owens W, Ungaro PC, Werk EE Jr, Wentz PW: Clay ingestion: a rare cause of hypokalemia. Ann Intern Med 97: 65–66, 1982.

    Article  PubMed  CAS  Google Scholar 

  157. Gennari FJ: Hypokalemia in metabolic alkalosis: a new look at an old controversy. In: M Hatano, ed, Nephrology. Proceedings of the XJth International Congress of Nephrology. Springer Verlag, Tokyo, pp 262–269, 1991.

    Google Scholar 

  158. Rimmer JM, Gennari FJ: Metabolic alkalosis. J Intensive Care Med 2: 137–150, 1987.

    Article  Google Scholar 

  159. Kassirer JP, Harrington JT: Diuretics and potassium metabolism: a reassessment of the need, effectiveness and safety of potassium therapy. Kidney Int 11: 505–515, 1977.

    Article  PubMed  CAS  Google Scholar 

  160. Nader PC, Thompson JR, Alpern RJ: Complications of diuretic use. Semin Nephrol 8: 365–387, 1988.

    PubMed  CAS  Google Scholar 

  161. Morgan DB, Davidson C: Hypokalaemia and diuretics: an analysis of publications. Br Med J 280: 905–908, 1980.

    Article  PubMed  CAS  Google Scholar 

  162. Licht JH, Haley RI, Pugh B, Lewis SB: Diuretic regimens in essential hypertension. A comparion of hypokalemic effects, BP control and cost. Arch Intern Med 143: 1694–1699, 1983.

    Article  PubMed  CAS  Google Scholar 

  163. Katz FH, Eckert RC, Gebott MD: Hypokalemia caused by surreptitious self-administration of diuretics. Ann Intern Med 76: 85–90, 1972.

    Article  PubMed  CAS  Google Scholar 

  164. Jamison RL, Ross JC, Kempson RL, Sufit CR, Parker TE: Surreptitious diuretic ingestion and pseudo-Bartter’s syndrome. Am J Med 73: 142–147, 1982.

    Article  PubMed  CAS  Google Scholar 

  165. Kassirer JP, Schwartz WB: The response of normal man to selective depletion of hydrochloric acid. Am J Med 40: 10–18, 1966.

    Article  PubMed  CAS  Google Scholar 

  166. Kassirer JP, Berkman PM, Lawrenz DR, Schwartz WB: The critical role of chloride in the correction of hypokalemic alkalosis in man. Am J Med 38: 172–189, 1965.

    Article  PubMed  CAS  Google Scholar 

  167. Harrington JT, Kassirer JP: Metabolic alkalosis. In: JJ Cohen, JP Kassirer (with the collaboration of FJ Gennari, JT Harrington, NE Madias), Acid-Base. Little, Brown, Boston, pp 227–306, 1982.

    Google Scholar 

  168. Veldhuis JD, Bardin CW, Demers LM: Metabolic mimicry of Bartter’s syndrome by covert vomiting. Am J Med 66: 36 1363, 1979.

    Google Scholar 

  169. Gill JR Jr, Bartter FC: Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter’s syndrome. Am J Med 65: 766–772, 1978.

    Article  PubMed  CAS  Google Scholar 

  170. Klastersky J, Vanderkelen B, Daneau D, Mathieu M: Carbenicillin and hypokalemia. Ann Intern Med 78: 774–775, 1973.

    Article  PubMed  CAS  Google Scholar 

  171. Brunner FP, Frick PG: Hypokalaemia, metabolic alkalosis, and hyponatraemia due to “massive” sodium penicillin therapy. Br Med J 4: 550–552, 1968.

    Article  PubMed  CAS  Google Scholar 

  172. Mohr JA, Clark RM, Waack TC, Whang R: Nafcillinassociated hypokalemia. JAMA 242: 544, 1979.

    CAS  Google Scholar 

  173. Gill MA, Dubé JE, Young WW: Hypokalemic, metabolic alkalosis induced by high-dose ampicillin sodium. Am J Hosp Pharm 34: 528–531, 1977.

    CAS  Google Scholar 

  174. Conn JW, Knopf RF, Nesbit RM: Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 107: 159–172, 1964.

    Article  PubMed  CAS  Google Scholar 

  175. Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, Yune HY, Wellman H, Donohue JP: Primary aldosteronism. Ann Intern Med 90: 386–395, 1979.

    Article  PubMed  CAS  Google Scholar 

  176. Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor SC. Giford RW, Vidt DG: The changing clinical spectrum of primary aldosteronism. Am J Med 74: 641–651, 1983.

    Article  PubMed  CAS  Google Scholar 

  177. Biglieri EG, Irony I, Kater CE: Adrenocortical forms of human hypertension. In: JH Laragh, BM Brenner, eds, Hypertension. Raven Press, New York, pp 1609–1624, 1990.

    Google Scholar 

  178. Kassirer JP, London AM, Goldman DM, Schwartz WB: On the pathogenesis of metabolic alkalosis in hyperaldosteronism. Am J Med 49: 306–315, 1973.

    Article  Google Scholar 

  179. Rich GM, Ulick S, Cook S, Wang JZ, Lifton RP, Dluhy RG: Glucocorticoid-remediable aldosteronism in a large kindred: Clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med 116: 813–820, 1992.

    Article  PubMed  CAS  Google Scholar 

  180. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel J: A chimaeric 11 ß-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355: 262–265, 1992.

    Article  PubMed  CAS  Google Scholar 

  181. Corvol P, Pinet F, Galen FX, Plouin PF, Chatellier G, Pagny JY, Bruneval P, Camilleri JP, Ménard J: Primary reninism In: JH Laragh, BM Brenner, eds, Hypertension. Raven Press, New York, pp 1573–1582, 1990.

    Google Scholar 

  182. Simon N, Franklin SS, Bleifer KH, Maxwell MH: Clinical characteristics of renovascular hypertension. DAMA 220: 1209–1218, 1972.

    CAS  Google Scholar 

  183. White RH, Schambelan M: Hypertension, hyperreninemia, and secondary hyperaldosteronism in systemic necrotizing vasculitis. Ann Intern Med 92: 199–201, 1980.

    Article  PubMed  CAS  Google Scholar 

  184. Ruby ST, Burch A, White WB: Unilateral renal artery stenosis seen initially as severe and symptomatic hypokalemia. Arch Surg 128: 346–348, 1993.

    Article  PubMed  CAS  Google Scholar 

  185. Edwards CRW, Walker BR, Benediktsson R, Seckl JR: Congenital and acquired syndromes of apparent mineralocorticoid excess. J Steroid Biochem Mol Biol 45: 1–5, 1993.

    Article  PubMed  CAS  Google Scholar 

  186. Biglieri EG, Kater CE: Mineralocorticoids in congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 40: 493–499, 1991.

    Article  PubMed  CAS  Google Scholar 

  187. Prunty FTG, Brooks RV, Dupré J, Gimlette TMD, Hutchinson JSM, McSwiney RR, Mills IH: Adrenocortical hyperfunction and potassium metabolism in patients with “non-endocrine” tumors and Cushing’s syndrome. J Clin Endocrinol Metab 23: 737–746, 1963.

    Article  PubMed  CAS  Google Scholar 

  188. Mantero F, Boscaro M: Glucocorticoid-dependent hypertension. J Steroid Biochem Mol Biol 43: 409–413, 1992.

    Article  PubMed  CAS  Google Scholar 

  189. Stewart PM, Come JET, Shackleton CHL, Edwards CRW: Syndrome of apparent mineralocorticoid excess. J Clin Invest 82: 340–349, 1988.

    Article  PubMed  CAS  Google Scholar 

  190. Clore J, Schoolwerth A, Watlington CO: When is cortisol a mineralocorticoid? Kidney Int 42: 1297–1308, 1992.

    Article  PubMed  Google Scholar 

  191. Stewart PM, Wallace AM, Valentine R, Burt D, Shackleton CHL, Edwards CRW: Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2: 821–824, 1987.

    Article  PubMed  CAS  Google Scholar 

  192. Farese RV, Biglieri EG, Shackleton CHL, Irony I, Gomez-Fontes R: Licorice-induced hypermineralocorticoidism. N Engl J Med 325: 1223–1227, 1991.

    Article  PubMed  Google Scholar 

  193. Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CRW: Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 1113- hydroxysteroid dehydrogenase activity in man. Clin Sci 217. Atchley DW, Loeb RF, Richards DW, Benedict EM, 78:49–54, 1990. Driscoll ME: On diabetic acidosis: a detailed study of electro-

    Google Scholar 

  194. Nielsen I, Pedersen RS: Life-threatening hypokalaemia lyte balances following the withdrawal and reestablishment caused by liquorice ingestion. Lancet 1:1305, 1984. of insulin therapy. J Clin Invest 12: 297–326, 1933.

    Article  Google Scholar 

  195. Young WF, Klee GG: Primary aldosteronism. Diagnostic 218. Brodsky WA, Rapoport S, West CD: The mechanism of evaluation. Endocrinol Metab Clin North Am 17:367–395, glycosuric diuresis in diabetic man. J Clin Invest 29:1021–1988. 1032, 1950.

    Google Scholar 

  196. Bravo EL: Primary aldosteronism. Urol Clin North Am 219. Adrogué HJ, Lederer ED, Suki WN, Eknoyan G: Determi- 16:481–486, 1989. nants of plasma potassium levels in diabetic ketoacidosis.

    Google Scholar 

  197. Biglieri EG: Spectrum of mineralocorticoid hypertension. Medicine 65:163–172, 1986. Hypertension 17:251–261, 1991. 220. Fulop M: Hyperkalemia in diabetic ketoacidosis. Am J Med

    Google Scholar 

  198. Bartter FC, Pronove P, Gill JR Jr, MacCardle RC: Sci 299:164–169, 1990. Hyperplasia of the juxtaglomerular complex with 221. Solomon R: The relationship between disorders of K’ and hyperaldosteronism and hypokalemic alkalosis. Am J Med Mg’ homeostasis. Semin Nephrol 7:253–262, 1987. 33:811–828, 1962. 222. Shils ME: Experimental human magnesium depletion. Medi-

    Google Scholar 

  199. Gill JR Jr: Bartter’s syndrome. Ann Rev Med 31:405–419, cine 48:61–85, 1969. 1980. 223. Shils ME: Experimental production of magnesium deficiency

    Google Scholar 

  200. Stein JH: The pathogenetic spectrum of Bartter’s syndrome. in man. Ann NY Acad Sci 162:847–855, 1969. Kidney Int 28:85–93, 1985. 224. Dunn MJ, Walser M: Magnesium depletion in normal man.

    Google Scholar 

  201. Fichman MP, Telfor N, Zia P, Speckart P, Golub M, Rude R: Metabolism 15:884–895, 1966. Role of prostaglandins in the pathogenesis of Bartter’s syn- 225. Evans RA, Carter JN, George CRP, Walls RS, Newland RC, drome. Am J Med 60:785–797, 1976. McDonnell GD, Lawrence JR: The congenital “magnesium-

    Google Scholar 

  202. Verbeckmoes R, van Damme B, Clement J, Amery A, losing kidney.“ Report of two patients. Q J Med 50:39–52, Michielsen P: Bartter’s syndrome with hyperplasia of 1981. renomedullary cells. Successful treatment with indo- 226. Whang R, Flink EB, Dyckner T, Wester PO, Aikawa JK, methacin. Kidney Int 9:302–307, 1976. Ryan MP: Magnesium depletion as a cause of refractory

    Google Scholar 

  203. Gill JR Jr, Frölich JC, Bowden RE, Taylor AA, Keiser HR, potassium repletion. Arch Intern Med 145:1686–1690, 1985. Seyberth HW, Oates JA, Bartter FC: Bartter’s syndrome. A 227. Rodriguez M, Solanki DL, Whang R: Refractory potassium disorder characterized by high urinary prostaglandins and a repletion due to cisplatin-induced magnesium depletion. dependence of hyperreninemia on prostaglandin synthesis. Arch Intern Med 149:2592–2594, 1989. Am J Med 61:43–51, 1976. 228. Holmes AM, Hesling CM, Wilson TM: Drug-induced sec-

    Google Scholar 

  204. Gitelman HJ: Hypokalemia, hypomagnesemia, and alkalosis: ondary hyperaldosteronism in patients with pulmonary tu- A rose is a rose—or is it? J Pediatr 120:79–80, 1992. berculosis. Q J Med 39: 299–315, 1970.

    Google Scholar 

  205. Gill JR Jr, Bell NH, Bartter FC: Impaired conservation of 229. Bar RS, Wilson HE, Mazzaferri EL: Hypomagnesemic sodium and potassium in renal tubular acidosis and its correc hypocalcemia secondary to renal magnesium wasting. A pos- tion by buffer anions. Clin Sci 33:577–592, 1967. sible consequence of high-dose gentamicin therapy. Ann In-

    Google Scholar 

  206. Gennari FJ, Cohen JJ: Renal tubular acidosis. Annu Rev Med tern Med 82:646–649, 1975. 29:521–541, 1978. 230. Gearhart MO, Sorg TB: Foscarnet-induced severe hypo-

    Google Scholar 

  207. Sebastian A, Hulter HN, Kurtz I, Maher T, Schambelan M: magnesemia and other electrolyte disorders. Ann Disorders of distal nephron function. Am J Med 72:289–307, Pharmacother 27:285–289, 1993. 1982. 231. Barton CH, Pahl M, Vaziri ND, Cesario T: Renal magnesium

    Google Scholar 

  208. Sebastian A, McSherry E, Morris RC Jr: Renal potassium wasting associated with amphotericin B therapy. Am J Med wasting in renal tubular acidosis (RTA). Its occurrence in 77:471–474, 1984. types 1 and 2 RTA despite sustained correction of systemic 232. Burgess JL, Birchall R: Nephrotoxicity of amphotericin B, acidosis. J Clin Invest 50:667–678, 1971. with emphasis on changes in tubular function. Am J Med

    Google Scholar 

  209. Wrong OM, Feest TG, Maclver AG: Immune-related 53:77–84, 1972. potassium-losing interstitial nephritis: a comparison with 233. Mir MA, Brabin B, Tang OT, Leyland MJ, Delamore IW:

    Google Scholar 

  210. distal renal tubular acidosis. Q J Med 86:513–534, Hypokalaemia in acute myeloid leukaemia. Ann Intern Med

    Google Scholar 

  211. :54–57, 1975.

    Google Scholar 

  212. Caruana RJ, Buckalew VM: The syndrome of distal (type I) 234. Fisher JR: Hypokalemia in leukemia. Ann Intern Med 86:363, renal tubular acidosis. Medicine 67: 84–99, 1988. 1977.

    Google Scholar 

  213. Lightwood R, Payne WW, Black JA: Infantile renal acidosis. 235. Lantz B, Carmark B, Reizenstein P: Electrolytes and whole

    Google Scholar 

  214. Pediatrics 12:628–644, 1953. body potassium in acute leukemia. Acta Med Scand 206:45-

    Google Scholar 

  215. Brenes LG, Brenes JN, Hernandez MM: Familial proximal 50, 1979.

    Google Scholar 

  216. renal tubular acidosis. Am J Med 63:244–252, 1977. 236. Perry MC, Bauer JH, Farhangi M: Hypokalemia in acute

    Google Scholar 

  217. Sebastian A, McSherry E, Morris RC Jr: On the mechanism myelogenous leukemia. South Med J 76:958–961, 1983. of potassium wasting in renal tubular acidosis associated with 237. Sterns RH, Cox M, Feig PU, Singer I: Internal potassium the Fanconi syndrome (type 2 RTA). J Clin Invest 50:231 balance and the control of the plasma potassium concentra- 243, 1971. tion. Medicine 60: 339–354, 1981.

    Article  Google Scholar 

  218. Harrington JT, Cohen JJ. Metabolic acidosis. In: JJ Cohen, 238. Lawson DH: Adverse reactions to potassium chloride. Q J JP Kassirer (with collaboration of FJ Gennari, JT Med 171:433–440, 1974. Harrington, NE Madias), Acid–Base. Little, Brown, Boston, 239. Ponce SP, Jennings AE, Madias NE, Harrington JT: Drugpp 121–225, 1982. indued hyperkalemia. Medicine 64:357–370, 1985.

    Google Scholar 

  219. Rimmer JM, Horn JF, Gennari FJ: Hyperkalemia as a complication of drug therapy. Arch Intern Med 147: 867–869, 1987.

    Article  PubMed  CAS  Google Scholar 

  220. Hultgren HN, Swenson R, Wettach G: Cardiac arrest due to oral potassium administration. Am J Med 58: 139–142, 1975.

    Article  PubMed  CAS  Google Scholar 

  221. McMahon FG, Ryan JR, Akdamar K, Ertan A: Effect of potassium chloride supplements on upper gastrointestinal mucosa. Clin Pharmacol Ther 35: 852–855, 1984.

    Article  PubMed  CAS  Google Scholar 

  222. Alsop WR, Moore JG, Rollins DE, Tolman KE: The effects of five potassium chloride preparations on the upper gastrointestinal mucosa in healthy subjects receiving glycopyrrolate. J Clin Pharmacol 24: 235–239, 1984.

    Article  PubMed  CAS  Google Scholar 

  223. Strom BL, Carson JL, Schinnar R, Sim E, Maislin G, Soper K, Morse L: Upper gastrointestinal tract bleeding from oral potassium chloride. Arch Intern Med 147: 954–957, 1987.

    Article  PubMed  CAS  Google Scholar 

  224. Schwartz AB, Swartz CD: Dosage of potassium chloride elixir to correct thiazide-induced hypokalemia. JAMA 230: 702–704, 1974.

    CAS  Google Scholar 

  225. Wan HH, Lye MDW. Moduretic-induced metabolic acidosis and hyperkalaemia. Postgrad Med J 56: 348–350, 1980.

    Article  PubMed  CAS  Google Scholar 

  226. Cohen AB: Hyperkalemic effects of triamterene. Ann Intern Med 65: 521–527, 1966.

    Article  PubMed  CAS  Google Scholar 

  227. Paice B, Gray JMB, McBride D, Donnelly T, Lawson DH: Hyperkalaemia in patients in hospital. Br Med J 286: 1189 1192, 1983.

    Google Scholar 

  228. Mather A, Mackie NR: Effects of hemolysis on serum electrolyte values. Clin Chem 6: 223–227, 1960.

    PubMed  CAS  Google Scholar 

  229. Bronson WR, DeVita VT, Carbone PP, Cotlove E: Pseudohyperkalemia due to release of potassium from white blood cells during clotting. N Engl J Med 274: 369–375, 1966.

    Article  PubMed  CAS  Google Scholar 

  230. Bellevue R, Dosik H, Spergel G, Gussoff BD: Pseudohyperkalemia and extreme leukocytosis. J Lab Clin Med 85: 660–664, 1975.

    PubMed  CAS  Google Scholar 

  231. Stewart GW, Corrall RJM, Fyffe JA, Stockdill G, Strong JA: Familial pseudohyperkalaemia: a new syndrome. Lancet 2: 175–177, 1979.

    Article  PubMed  CAS  Google Scholar 

  232. Graber M, Subramani K, Corish D, Schwab A: Thrombocytosis elevates serum potassium. Am J Kidney Dis 12: 116–120, 1988.

    PubMed  CAS  Google Scholar 

  233. Lum G, Gambino SR: A comparison of serum versus heparinized plasma for routine chemistry tests. Am J Clin Pathol 61: 108–113, 1974.

    PubMed  CAS  Google Scholar 

  234. Ladenson JH, Tsai LB, Michael JM, Kessler G, Joist JH: Serum versus heparinized plasma for eighteen common chemistry tests. Am J Clin Pathol 62: 545–552, 1974.

    PubMed  CAS  Google Scholar 

  235. Hartmann RC, Auditore JV, Jackson DP: Studies on thrombocytosis. I. Hyperkalemia due to release of potassium from platelets during coagulation. J Clin Invest 37: 699–707, 1958.

    Article  PubMed  CAS  Google Scholar 

  236. Kerr DJ, McAlpine LG, Dagg JH: Pseudohyperkalaemia. Br Med J 291: 890–891, 1985.

    Article  CAS  Google Scholar 

  237. Don BR, Sebastian A, Cheitlin M, Christiansen M, Schambelan M: Pseudohyperkalemia caused by fist clenching during phlebotomy. N Engl J Med 322: 1290–1292, 1990.

    Article  PubMed  CAS  Google Scholar 

  238. Finch CA, Sawyer CG, Flynn JM: Clinical syndrome of potassium intoxication. Am J Med 1: 337–352, 1946.

    Article  PubMed  CAS  Google Scholar 

  239. Pollen RH, Williams RH: Hyperkalemic neuromyopathy in Addison’s disease. N Engl J Med 263: 273–278, 1962.

    Article  Google Scholar 

  240. Davis JO, Urquhart J, Higgins JT Jr: The effects of alterations of plasma sodium and potassium concentration on aldosterone secretion. J Clin Invest 42: 597–609, 1963.

    Article  PubMed  CAS  Google Scholar 

  241. Fredlund P, Saltman S, Kondo T, Douglas J, Catt KJ: Aldosterone production by isolated glomerulosa cells: modulation of sensitivity to angiotensin II and ACTH by extracellular potassium concentration. Endocrinology 100: 481–486, 1977.

    Article  PubMed  CAS  Google Scholar 

  242. Miller PD, Waterhouse C, Owens R, Cohen E: The effect of potassium loading on sodium excretion and plasma renin activity in Addisonian man. J Clin Invest 56: 346–353, 1975.

    Article  PubMed  CAS  Google Scholar 

  243. van Ypersele de Strihou C: Potassium homeostasis in renal failure. Kidney Int 11: 491–504, 1977.

    Article  PubMed  Google Scholar 

  244. Gonick HC, Kleeman CR, Rubin ME, Maxwell MH: Functional impairment in chronic renal disease III. Studies of potassium excretion. Am J Med Sci 261: 281–290, 1971.

    Article  PubMed  CAS  Google Scholar 

  245. Perez GO, Pelleya R, Oster JR, Kem DC, Vaamonde CA: Blunted kaliuresis after an acute potassium load in patients with chronic renal failure. Kidney Int 24: 656–662, 1983.

    Article  PubMed  CAS  Google Scholar 

  246. Kahn T, Kaji DM, Nicolis G, Krakoff LR, Stein RM: Factors related to potassium transport in chronic stable renal disease in man. Clin Sci Mol Med 54: 661–666, 1978.

    PubMed  CAS  Google Scholar 

  247. Bergström J, Alvestrand A, Fürst P, Hultman E, WidstamAttorps U: Muscle intracellular electrolytes in patients with chronic uremia. Kidney Int 24 (Suppl 16): S153 — S160, 1983.

    Google Scholar 

  248. Boddy K, King PC, Lindsay RM, Briggs JD, Winchester JF, Kennedy AC: Total body potassium in non-dialyzed and dialyzed patients with chronic renal failure. Br Med J 1: 771–775, 1972.

    Article  PubMed  CAS  Google Scholar 

  249. Widmer B, Gerhardt RE, Harrington JT, Cohen JJ: Serum electrolyte and acid—base composition. The influence of graded degrees of chronic renal failure. Arch Intern Med 139: 1099–1102, 1979.

    Article  PubMed  CAS  Google Scholar 

  250. Restuccio A: Fatal hyperkalemia from a salt substitute. Am J Emerg Med 10: 171–173, 1992.

    Article  PubMed  CAS  Google Scholar 

  251. Sopko JA, Freeman RM: Salt substitutes as a source of potassium. JAMA 238: 608–610, 1977.

    CAS  Google Scholar 

  252. Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA: Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes 37: 1470–1477, 1988.

    Article  PubMed  CAS  Google Scholar 

  253. DeFronzo RA: Obesity is associated with impaired insulin-mediated potassium uptake. Metabolism 37: 105–108, 1988.

    Article  PubMed  CAS  Google Scholar 

  254. Cohen P, Barzilai N, Lerman A, Hard H, Szylman P, Karnieli E: Insulin effects on glucose and potassium metabolism in vivo: evidence for selective insulin resistance in humans. J Clin Endocrinol Metab 73: 564–568, 1991.

    Article  PubMed  CAS  Google Scholar 

  255. DeFronzo RA: Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int 17: 118–134, 1980.

    Article  PubMed  CAS  Google Scholar 

  256. Sunderlin FS, Anderson GH, Streeten DHP, Blumenthal SA: The renin—angiotensin—aldosterone system in diabetic patients with hyperkalemia. Diabetes 30: 335–340, 1981.

    Article  PubMed  CAS  Google Scholar 

  257. Conte G, Dal Canton A, Imperatore P, DeNicola L, Gigliotti G, Pisanti N, Memoli B, Furiano G, Esposito C, Andreucci VE: Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. Kidney Int 38: 301–307, 1990.

    Article  PubMed  CAS  Google Scholar 

  258. Goldfarb S, Cox M, Singer I, Goldberg M: Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms. Ann Intern Med 84: 426–432, 1976.

    Article  PubMed  CAS  Google Scholar 

  259. Perez GO, Lespier L, Knowles R, Oster JR, Vaamonde CA: Potassium homeostasis in chronic diabetes mellitus. Arch Intern Med 137: 1018–1022, 1977.

    Article  PubMed  CAS  Google Scholar 

  260. Perez GO, Lespier L, Jacobi J, Oster JR, Katz FH, Vaamonde C, Fishman LM: Hyporeninemia and hypoaldosteronism in diabetes mellitus. Arch Intern Med 137: 852–855, 1977.

    Article  PubMed  CAS  Google Scholar 

  261. Arrizabalaga P, Montoliu J, Martinez-Vea A, Andreu L, Lopez-Pedret J, Revert L: Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone. Proc Eur Dial Transplant Assoc 20: 572–576, 1983.

    PubMed  CAS  Google Scholar 

  262. Arthur S, Greenberg A: Hyperkalemia associated with intravenous labetabol therapy for acute hypertension in renal transplant recipients. Clin Nephrol 33: 269–271, 1990.

    PubMed  CAS  Google Scholar 

  263. Fletcher GF, Fletcher BJ, Sweeney ME: Effects of exercise testing, training and beta blockade on serum potassium in normal subjects. Am J Cardiol 65: 1242–1245, 1990.

    Article  PubMed  CAS  Google Scholar 

  264. Castellino P, Bia MJ, DeFronzo RA: Adrenergic modulation of potassium metabolism in uremia. Kidney Int 37: 793–798, 1990.

    Article  PubMed  CAS  Google Scholar 

  265. Ericsson F, Carlmark B, Jogestrand T, Sundqvist K: Effect of digoxin upon intracellular potassium in man. Scand J Clin Lab Invest 41: 457–463, 1981.

    Article  PubMed  CAS  Google Scholar 

  266. Bismuth C,. Gaultier M, Conso F, Efthymiou ML: Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol 6: 153–162, 1973.

    Article  Google Scholar 

  267. Smith TW, Butler VP Jr, Haber E, Fozzard H, Marcus FI, Bremner WF, Schulman IC, Phillips A: Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. N Engl J Med 307: 1357–1362, 1982.

    Article  PubMed  CAS  Google Scholar 

  268. Reza MJ, Kovick RB, Shine KI, Pearce ML: Massive intravenous digoxin overdosage. N Engl J Med 291: 777 778, 1974.

    Google Scholar 

  269. Papadakis MA, Wexman MP, Fraser C, Sedlacek SM: Hyperkalemia complicating digoxin toxicity in a patient with renal failure. Am J Kidney Dis 5: 64–66, 1985.

    PubMed  CAS  Google Scholar 

  270. Evers W, Racz GB, Dobkin AB: A study of plasma potassium and electrocardiographic changes after a single dose of succinylcholine. Can Anesth Soc J 16: 273–281, 1969.

    Article  CAS  Google Scholar 

  271. Weintraub HD, Heisterkamp DV, Cooperman LH: Changes in plasma potassium concentration after depolarizing blockers in anaesthetized man. Br J Anaesth 41: 1048–1052, 1969.

    Article  PubMed  CAS  Google Scholar 

  272. Cooperman L: Succinylcholine-induced hyperkalemia in neuromuscular disease. JAMA 213: 1867–1871, 1970.

    CAS  Google Scholar 

  273. Brooke MM, Donovan WH, Stolov WC: Paraplegia: succinylcholine-induced hyperkalemia and cardiac arrest. Arch Phys Med Rehab 59: 306–309, 1978.

    CAS  Google Scholar 

  274. Greenawalt JW 3rd: Succinylcholine-induced hyperkalemia 8 weeks after a brief paraplegic episode. Anesth Analg 75: 294295, 1992.

    Google Scholar 

  275. Dickerman HW, Walker WG: Effect of cationic amino acid infusion on potassium metabolism in vivo. Am J Physiol 206: 403–408, 1964.

    PubMed  CAS  Google Scholar 

  276. Levinsky NG, Tyson I, Miller RB, Reiman AS: The relation between amino acids and potassium in isolated rat muscle. J Clin Invest 41: 480–487, 1962.

    Article  PubMed  CAS  Google Scholar 

  277. Hertz P, Richardson JA: Arginine-induced hyperkalemia in renal failure patients. Arch Intern Med 130: 778–780, 1982.

    Article  Google Scholar 

  278. Bushinsky DA, Gennari FJ: Life-threatening hyperkalemia induced by arginine. Ann Intern Med 89: 632–634, 1978.

    Article  PubMed  CAS  Google Scholar 

  279. McIvor M, Baltazar RF, Beltran J, Mower MM, Wenk R, Lustgarten J, Salomon J: Hyperkalemia and cardiac arrest from fluoride exposure during hemodialysis. Am J Cardiol 51: 901–902, 1983.

    Article  PubMed  CAS  Google Scholar 

  280. Gabow PA, Kaehny WD, Kelleher SP: The spectrum of rhabdomyolysis. Medicine 61: 141–152, 1982.

    Article  PubMed  CAS  Google Scholar 

  281. Bluemle LW Jr, Webster GD, Elkinton JR: Acute tubular necrosis: analysis of one hundred cases with respect to mortality, complications and treatment with and without dialysis. Arch Intern Med 104: 180–197, 1959.

    Article  Google Scholar 

  282. Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M: Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med 291: 807–811, 1974.

    Article  PubMed  CAS  Google Scholar 

  283. Gamstorp I, Hauge M, Helweg-Larsen HF, Mjönes H, Sagild U: Adynamica episodica hereditaria. Am J Med 23: 385–390, 1957.

    Article  PubMed  CAS  Google Scholar 

  284. Ptacek LJ, Johnson KJ, Griggs RC: Genetics and physiology of the myotonic muscle disorders. N Engl J Med 328: 482–489, 1993.

    Article  PubMed  CAS  Google Scholar 

  285. Ptacek LJ, George AL Jr, Griggs RC, Tawil R, Kallen RG, Barchi RL, Robertson M, Leppert MF: Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67: 1021–1027, 1991.

    Article  PubMed  CAS  Google Scholar 

  286. Fontaine B, Khurana TS, Hoffman EP, Bruns GAP, Haines JL, Trofatter JA, Hanson MP, Rich J, McFarlane H, Yasek DM, Romano D, Gusella JF, Brown RH Jr: Hyperkalemic periodic paralysis and the adult muscle sodium channel a-subunit gene. Science 250: 1000–1002, 1990.

    Article  PubMed  CAS  Google Scholar 

  287. Cannon SC, Brown RH Jr, Corey DP: A sodium channel defect in hyperkalemic periodic paralysis: potassium-induced failure of inactivation. Neuron 6: 619–626, 1991.

    Article  PubMed  CAS  Google Scholar 

  288. Streeten DHP, Dalakos TG, Fellerman H: Studies on hyperkalemic periodic paralysis. Evidence of changes in plasma Na and Cl and induction of paralysis by adrenal glucocorticoids. J Clin Invest 50: 142–155, 1971.

    Article  PubMed  CAS  Google Scholar 

  289. Wang P, Clausen T: Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Lancet 1: 221–223, 1976.

    Article  PubMed  CAS  Google Scholar 

  290. Martin RS, Panese S. Virginillo M, Gimenez M, Litardo M, Arrizurieta E, Hayslett JP: Increased secretion of potassium in the rectum of humans with chronic renal failure. Am J Kidney Dis 8: 105–110, 1986.

    PubMed  CAS  Google Scholar 

  291. Hou S, McElroy PA, Nootens J, Beach M: Safety and efficacy of low-potassium dialysate. Am J Kidney Dis 13: 137–143, 1989.

    PubMed  CAS  Google Scholar 

  292. Gennari FJ, Rimmer JM: Disturbances in fluid, electrolyte, and acid-base balance. Part 2. Dialysis patients. In: SG Massry, RJ Glassock, eds, Textbook of Nephrology, 3rd ed. Williams and Wilkins, Baltimore, pp 1434–1440, 1995.

    Google Scholar 

  293. Greenblatt DJ, Koch-Weser J: Adverse reactions to spironolactone. DAMA 225: 40–43, 1973.

    CAS  Google Scholar 

  294. Walker BR, Capuzzi DM, Alexander F, Familiar RG, Hoppe RC: Hyperkalemia after triamterene in diabetic patients. Clin Pharmacol Ther 13: 643–651, 1972.

    PubMed  CAS  Google Scholar 

  295. Feinfeld DA, Carvounis CP: Fatal hyperkalemia and hyperchloremic acidosis. DAMA 240: 1516, 1978.

    CAS  Google Scholar 

  296. McNay JL, Oran E: Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK870). Metabolism 19: 58–70, 1970.

    Article  PubMed  CAS  Google Scholar 

  297. Atlas SA, Case DB, Sealey JE, Laragh JH, McKinstry DN: Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natriuresis. Hypertension 1: 274–280, 1979.

    Article  PubMed  CAS  Google Scholar 

  298. Textor SC, Bravo EL, Fouad FM, Tarazi RC: Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. Am J Med 73: 719–725, 1982.

    Article  PubMed  CAS  Google Scholar 

  299. Bauer JH: Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Am J Med 77 (Suppl 2A): 43–51, 1984.

    PubMed  CAS  Google Scholar 

  300. Zachariah PK, Bonnet G, Chysant SG, DeBackser G, Goldstein R, Herrera J, Lindner A, Materson BJ, Maxwell MH, McMahon FG, Merrill RH, Paton RR, Rapp AD, Roginsky MS, Seedat YK, Sime F, Vaicaitis JS, Weinberg MS, Zusman RM: Evaluation of antihypertensive efficacy of lisinopril compared to metaprolol in moderate to severe hypertension. J Cardiovasc Pharmacol 9 (Suppl 3): S53 - S58, 1987.

    Article  PubMed  Google Scholar 

  301. Donohoe JF, Laher M, Doyle GD, Cooper WD: Lisinopril in hypertension associated with renal impairment. J Cardiovasc Pharmacol 9 (Suppl 3): S66 - S68, 1987.

    Article  PubMed  Google Scholar 

  302. deJong PE, Apperloo AJ, Heeg JE, deZeeuw D: Lisinopril in hypertensive patients with renal function impairment. Nephron 55 (Suppl 1): 43–48, 1990.

    Article  Google Scholar 

  303. Doman K, Perlmutter JA, Muhammedi M, Puschett JB: Life-threatening hyperkalemia associated with captopril administration. South Med J 86: 1269–1272, 1993.

    Article  PubMed  CAS  Google Scholar 

  304. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456–1462, 1993.

    Article  PubMed  CAS  Google Scholar 

  305. Feig PU, Rutan GH: Angiotensin converting enzyme inhibitors: The end of end-stage renal disease? Ann Intern Med 111: 451–453, 1989.

    Article  PubMed  CAS  Google Scholar 

  306. Praga M, Hernandez E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL: Long-term beneficial effects of angiotensinconverting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20: 240–248, 1992.

    PubMed  CAS  Google Scholar 

  307. Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol 2: 755–763, 1983.

    Article  Google Scholar 

  308. Tan SY, Shapiro R, Franco R, Stockard H, Mulrow PJ: Indomethacin-induced prostaglandin inhibition with hyperkalemia. Ann Intern Med 90: 783–785, 1979.

    Article  PubMed  CAS  Google Scholar 

  309. Clive DM, Stoff JS: Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 310: 563–572, 1984.

    Article  PubMed  CAS  Google Scholar 

  310. Whelton A, Hamilton CW: Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol 31: 588598, 1991.

    Google Scholar 

  311. Rotenberg FA, Giannini VS: Hyperkalemia associated with ketorolac. Ann Pharmacother 26: 778–779, 1992.

    PubMed  CAS  Google Scholar 

  312. Wilson ID, Goetz FC: Selective hypoaldosteronism after prolonged heparin administration. Am J Med 36: 635–640, 1964.

    Article  PubMed  CAS  Google Scholar 

  313. Conn JW, Rovner DR, Cohen EL, Anderson JE Jr: Inhibition by heparinoid of aldosterone biosynthesis in man. J Clin Endocrinol Metab 26: 527–532, 1966.

    Article  PubMed  CAS  Google Scholar 

  314. Busch EH, Ventura HO, Lavie CJ: Heparin-induced hyperkalemia. South Med J 80: 1450–1451, 1987.

    Article  PubMed  CAS  Google Scholar 

  315. Aull L, Chao H, Coy K: Heparin-induced hyperkalemia. DICP Ann Pharmacother 24: 244–246, 1990.

    CAS  Google Scholar 

  316. Edes TE, Sunderrajan EV: Heparin-induced hyperkalemia. Arch Intern Med 145: 1070–1072, 1985.

    Article  PubMed  CAS  Google Scholar 

  317. Adu D, Turney J, Michael J, McMaster P: Hyperkalaemia in cyclosporin-treated renal allograft recipients. Lancet 2: 370372, 1983.

    Google Scholar 

  318. Bantle JP, Nath KA, Sutherland DER, Najarian JS, Ferris TF: Effects of cyclosporine on the renin-angiotensinaldosterone system and potassium excretion in renal transplant recipients. Arch Intern Med 145: 505–508, 1985.

    Article  PubMed  CAS  Google Scholar 

  319. Kamel KS, Ethier JH, Quaggin S, Levin A, Albert S, Carlisle EJF, Halperin ML: Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. J Am Soc Nephrol 2: 1279–1284, 1991.

    Google Scholar 

  320. Bantle JP, Boudreau RJ, Ferris TF: Suppression of plasma renin activity by cyclosporine. Am J Med 83: 59–64, 1987.

    Article  PubMed  CAS  Google Scholar 

  321. Choi MJ, Fernandez PC, Patnaik A, Coupaye-Gerard B, D’Andrea D, Szerlip H, Kleyman TR: Trimethopriminduced hyperkalemia in a patient with AIDS. N Engl J Med 328: 703–706, 1993.

    Article  PubMed  CAS  Google Scholar 

  322. Velazquez H, Perazella MA, Wright FS, Ellison DH: Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med 119: 296–301, 1993.

    Article  PubMed  CAS  Google Scholar 

  323. Lachaal M, Venuto RC: Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine. Am J Med 87: 260–263, 1989.

    Article  PubMed  CAS  Google Scholar 

  324. Briceland LL, Bailie GR: Pentamidine-associated nephrotoxicity and hyperkalemia in patients with AIDS. DICP 25: 1171–1174, 1991.

    CAS  Google Scholar 

  325. Nerup J: Addison’s disease—clinical studies. A report of 108 cases. Acta Endocrinol 76: 127–141, 1974.

    PubMed  CAS  Google Scholar 

  326. Smith SJ, MacGregor GA, Markandu ND, Bayliss J, Banks RA, Prentice MG, Dorrington-Ward P, Wise P: Evidence that patients with Addison’s disease are undertreated with fludrocortisone. Lancet 1: 11–14, 1984.

    Article  PubMed  CAS  Google Scholar 

  327. Yamamoto T, Fukuyama J, Hasegawa K, Sugiura M: Isolated corticotropin deficiency in adults. Arch Intern Med 152: 1705 1712, 1992.

    Google Scholar 

  328. Ross EJ, van’t Hoff W, Crabbe J, Thorn GW: Aldosterone excretion in hypopituitarism and after hypophysectomy in man. Am J Med 28: 229–238, 1960.

    CAS  Google Scholar 

  329. Schambelan M, Sebastian A, Biglieri EG: Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency. Kidney Int 17: 89–101, 1980.

    Article  PubMed  CAS  Google Scholar 

  330. Nadler JL, Lee FO, Hsueh W, Horton R: Evidence of prostacyclin deficiency in the syndrome of hyporeninemic hypoaldosteronism. N Engl J Med 314: 1015–1020, 1986.

    Article  PubMed  CAS  Google Scholar 

  331. Bryan GT, Kliman B, Bartter FC: Impaired aldosterone production in “salt losing” congenital adrenal hyperplasia. J Clin Invest 44: 957–965, 1965.

    Article  PubMed  CAS  Google Scholar 

  332. Ulick S, Eberlin WR, Bliffeld AR, Chu MD, Bongiovanni AM: Evidence for an aldosterone biosynthetic defect in congenital adrenal hyperplasia. J Clin Endocrinol Metab 51: 1346–1353, 1980.

    Article  PubMed  CAS  Google Scholar 

  333. Hamilton W, McCandless AE, Ireland JT, Gray CE: Hypoaldosteronism in three sibs due to 18-dehydrogenase deficiency. Arch Dis Child 51: 576–583, 1976.

    Article  PubMed  CAS  Google Scholar 

  334. Veldhuis JD, Kulin HE, Santen RJ, Wilson TE, Melby JC: Inborn error in the terminal step of aldosterone biosynthesis. N Engl J Med 303: 117–121, 1980.

    Article  PubMed  CAS  Google Scholar 

  335. Braithwaite SS, Barbato AL, Emanuele MA: Acquired partial corticosterone methyl oxidase type II defect in diabetes mellitus. Diabetes Care 13: 790–792, 1990.

    Article  PubMed  CAS  Google Scholar 

  336. Oberfield SE, Levine LS, Carey RM, Bejar R, New MI: Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab 48: 228–234, 1979.

    Article  PubMed  CAS  Google Scholar 

  337. Armanini D, Kuhnle U, Strasser T, Dorr H, Butenandt I, Weber PC, Stockigt JR, Pearce P, Funder JW: Aldosteronereceptor deficiency in pseudohypoaldosteronism. N Engl J Med 313: 1178–1181, 1985.

    Article  PubMed  CAS  Google Scholar 

  338. Armanini D, Wehling M, DaDalt L, Zennaro M, Scali U, Keller U, Pratesi C, Mantero F, Kuhnle U: Pseudohypoaldosteronism and mineralocorticoid receptor abnormalities. J Steroid Biochem Mol Biol 40: 363–365, 1991.

    Article  PubMed  CAS  Google Scholar 

  339. Brautbar N, Levi J, Rosler A, Leitesdorf E, Djaldeti M, Epstein M, Kleeman CR: Familial hyperkalemia, hypertension and hyporeninemia with normal aldosterone levels. Arch Intern Med 138: 607–610, 1978.

    Article  PubMed  CAS  Google Scholar 

  340. Schambelan M, Sebastian A, Rector FC Jr: Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. Kidney Int 19: 716–727, 1981.

    Article  PubMed  CAS  Google Scholar 

  341. Take C, Ikeda K, Kurasawa T, Kurokawa K: Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism. N Engl J Med 324: 472–476, 1991.

    Article  PubMed  CAS  Google Scholar 

  342. DeFronzo RA, Cooke R, Goldberg M, Cox M, Myers AR, Agus ZS: Impaired renal tubular potassium secretion in systemic lupus erythematosus. Ann Intern Med 86: 268–271, 1977.

    Article  PubMed  CAS  Google Scholar 

  343. Battle D, Itsarayoungyuen K, Arruda JAL, Kurtzman NA: Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies. Am J Med 72: 188–192, 1982.

    Article  Google Scholar 

  344. Batlle DC: Segmental characterization of defects in collecting tubule acidification. Kidney Int 30: 546–554, 1986.

    Article  PubMed  CAS  Google Scholar 

  345. Battle DC, Arruda JAL, Kurtzman NA: Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med 304: 373–380, 1981.

    Article  Google Scholar 

  346. Cogan MG, Arieff AI: Sodium wasting, acidosis and hyperkalemia induced by methicillin interstitial nephritis. Am J Med 64: 500–507, 1978.

    Article  PubMed  CAS  Google Scholar 

  347. Chamberlain MJ: Emergency treatment of hyperkalaemia. Lancet 1: 464–467, 1964.

    Article  PubMed  CAS  Google Scholar 

  348. Garcia-Palmieri MR: Reversal of hyperkalemic cardiotoxicity with hypertonic saline. Am Heart J 64: 483–488, 1962.

    Article  PubMed  CAS  Google Scholar 

  349. Ballantyne F III, Davis LD, Reynolds EW Jr: Cellular basis for reversal of hyperkalemic electrocardiographic changes by sodium. Am J Physiol 229: 935–940, 1975.

    PubMed  CAS  Google Scholar 

  350. Blumberg A, Weidmann P, Shaw S, Gnädinger M: Effect of various therapeutic approaches on plasma potassium and major regulatory factors in terminal renal failure. Am J Med 85: 507–512, 1988.

    Article  PubMed  CAS  Google Scholar 

  351. Alton M, Dunlay R, Copkney C: Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 110: 426–429, 1989.

    Article  Google Scholar 

  352. Montoliu J, Lens XM, Revert L: Potassium-lowering effect of albuterol for hyperkalemia in renal failure. Arch Intern Med 147: 713–717, 1987.

    Article  PubMed  CAS  Google Scholar 

  353. Blumberg A, Weidmann P, Ferrari P: Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 41: 369–374, 1992.

    Article  PubMed  CAS  Google Scholar 

  354. Fraley DS, Adler S: Correction of hyperkalemia by bicarbonate despite constant blood pH. Kidney Int 12: 354–360, 1977.

    Article  PubMed  CAS  Google Scholar 

  355. Flinn RB, Merrill JP, Welzant WR: Treatment of the oliguric patient with a new sodium-exchange resin and sorbitol. N Engl J Med 264: 111–115, 1961.

    Article  PubMed  CAS  Google Scholar 

  356. Greenman L, Peters JH, Mateer FM, Danowski TS: Probable clinical utility of cation exchange resins. J Clin Invest 30: 1027–1031, 1951.

    Article  PubMed  CAS  Google Scholar 

  357. Scherr L, Ogden DA, Mead AW, Spritz N, Rubin AL: Management of hyperkalemia with a cation-exchange resin. N Engl J Med 264: 115–119, 1961.

    Article  PubMed  CAS  Google Scholar 

  358. Kramer P, Levitan R: Effect of 9-a-fluorohydrocortisone on the ileal excreta of ileostomized subjects. Gastroenterology 62: 235–241, 1972.

    PubMed  CAS  Google Scholar 

  359. Clarke AM, Hill GL, MacBeth WAAG: Intestinal adaptation to salt depletion in a patient with an ileostomy. Gastroenterology 53: 444–449, 1967.

    Google Scholar 

  360. Evans BM, Hughes-Jones NC, Milne MD, Yellowlees H: Ion-exchange resins in treatment of anuria. Lancet 2: 79 1795, 1953.

    Google Scholar 

  361. Emmett M, Hootkins R, Santa Ana CA, Porter JL, Fordtran JS: Effect of three laxatives and a cation exchange resin on fecal sodium and potassium excretion. Gastroenterology 108: 752–760, 1995.

    Article  PubMed  CAS  Google Scholar 

  362. Lillemoe KD, Romolo JL, Hamilton SR, Pennington LR, Burdick JF, Williams GM: Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery 101: 267–272, 1987.

    PubMed  CAS  Google Scholar 

  363. Wootton FT, Rhodes DF, Lee WM, Fitts CT: Colonic necrosis with kayexelate-sorbitol enemas after renal transplantation. Ann Intern Med 111: 947–949, 1989.

    Article  PubMed  CAS  Google Scholar 

  364. Gerstman BB, Kirkman R, Platt R: Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfate in sorbitol. Am J Kidney Dis 20: 159–161, 1992.

    PubMed  CAS  Google Scholar 

  365. Berlyne GM, Janabi K, Shaw AB: Dangers of resonium A in the treatment of hyperkalaemia in renal failure. Lancet 1: 167–169, 1966.

    Article  PubMed  CAS  Google Scholar 

  366. Alton M: Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int 43: 1197–1209, 1993.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Wadi N. Suki M.D. Shaul G. Massry M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gennari, F.J. (1998). Disorders of Potassium Metabolism. In: Suki, W.N., Massry, S.G. (eds) Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6632-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6632-5_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6634-9

  • Online ISBN: 978-1-4757-6632-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics